(Q37790294)

23 August 2017

Understanding the role of tumor stem cells in glioblastoma multiforme: a review article (English)

1 reference

23 August 2017

1 reference

neoplastic stem cells

1 reference

1 reference

Aalya Fatoo

1

1 reference

23 August 2017

Michael J Nanaszko

2

1 reference

23 August 2017

Baxter B Allen

3

1 reference

23 August 2017

Christina L Mok

4

1 reference

23 August 2017

Elena N Bukanova

5

1 reference

23 August 2017

Robel Beyene

6

1 reference

23 August 2017

Jennifer A Moliterno

7

1 reference

23 August 2017

John A Boockvar

8

1 reference

23 August 2017

18 September 2010

1 reference

Journal of Neuro-Oncology

23 August 2017

1 reference

23 August 2017

103

1 reference

23 August 2017

3

1 reference

23 August 2017

397-408

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-010-0406-3

23 August 2017

0 references

cites work

Central nervous system tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

A direct measurement of the radiation sensitivity of normal mouse bone marrow cells

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

21 January 2018

12 December 2020

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Cancerous stem cells can arise from pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Glioma stem cells: a midterm exam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Direct isolation of human central nervous system stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Stem cell marker CD133 affects clinical outcome in glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Influence of oxygen tension on CD133 phenotype in human glioma cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

CD133: molecule of the moment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

21 January 2018

Brain tumour stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Stem cell markers in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Function of RNA-binding protein Musashi-1 in stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Expression of stem cell markers in human astrocytomas of different WHO grades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Targeting cancer stem cells through L1CAM suppresses glioma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Integrin alpha 6 regulates glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

BMI1 sustains human glioblastoma multiforme stem cell renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Glioblastoma cell growth is suppressed by disruption of Fibroblast Growth Factor pathway signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

The Myc oncoprotein as a therapeutic target for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Hedgehog signaling regulates brain tumor-initiating cell proliferation and portends shorter survival for patients with PTEN-coexpressing glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Notch signaling: cell fate control and signal integration in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Contribution of Notch signaling activation to human glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Targeting A20 decreases glioma stem cell survival and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Molecular mechanisms of HIF-1alpha modulation induced by oxygen tension and BMP2 in glioblastoma derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Role of Wnt5a in the proliferation of human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Wnt signalling regulates adult hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

p53 suppresses the self-renewal of adult neural stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Comparative analysis of DNA repair in stem and nonstem glioma cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Temozolomide preferentially depletes cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Oncolytic herpes simplex virus type-1 therapy in a highly infiltrative animal model of human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Brain cancer stem cells display preferential sensitivity to Akt inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Phase ib trial of oncolytic herpes virus G207 shows safety of multiple injections and documents viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Glioma-associated cancer-initiating cells induce immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Transfection of neuroprogenitor cells with iron nanoparticles for magnetic resonance imaging tracking: cell viability, differentiation, and intracellular localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Making a tumour's bed: glioblastoma stem cells and the vascular niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Microvessel density is a prognostic indicator for patients with astroglial brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

A perivascular niche for brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Novel anti-angiogenic therapies for malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Developmental signaling pathways in brain tumor-derived stem-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

All-trans-retinoic acid: a phase II Radiation Therapy Oncology Group study (RTOG 91-13) in patients with recurrent malignant astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

Differentiation therapy exerts antitumor effects on stem-like glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0406-3

A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.

21 January 2018

1 reference

12 December 2020

Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo

1 reference

12 December 2020

NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53.

1 reference

12 December 2020

NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts

1 reference

12 December 2020

A gene delivery system with a human artificial chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells

1 reference

12 December 2020

Characterization of the human nestin gene reveals a close evolutionary relationship to neurofilaments

1 reference

12 December 2020

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

1 reference

12 December 2020

Notch promotes radioresistance of glioma stem cells

1 reference

12 December 2020

Presence of pluripotent CD133+ cells correlates with malignancy of gliomas.

1 reference

12 December 2020

Identification of a cancer stem cell in human brain tumors

1 reference

12 December 2020

Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells

1 reference

12 December 2020

Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions

1 reference

12 December 2020

AC133, a novel marker for human hematopoietic stem and progenitor cells

1 reference

12 December 2020

Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo.

1 reference

12 December 2020

Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.

1 reference

12 December 2020

10.1007/S11060-010-0406-3

Identifiers

DOI

1 reference

23 August 2017

1 reference